MCID: STM003
MIFTS: 19

Stomach Carcinoma in Situ

Categories: Cancer diseases, Gastrointestinal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Stomach Carcinoma in Situ

MalaCards integrated aliases for Stomach Carcinoma in Situ:

Name: Stomach Carcinoma in Situ 12 15
Carcinoma in Situ of Stomach 12 74
Gastric Carcinoma in Situ 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9138
ICD9CM 36 230.2
SNOMED-CT 69 92756002
ICD10 34 D00.2
UMLS 74 C0154060

Summaries for Stomach Carcinoma in Situ

Disease Ontology : 12 An in situ carcinoma that is located in the stomach.

MalaCards based summary : Stomach Carcinoma in Situ, also known as carcinoma in situ of stomach, is related to lip carcinoma in situ and esophagus carcinoma in situ. An important gene associated with Stomach Carcinoma in Situ is CRLF1 (Cytokine Receptor Like Factor 1). The drugs Fluorouracil and Oxaliplatin have been mentioned in the context of this disorder. Affiliated tissues include the stomach.

Related Diseases for Stomach Carcinoma in Situ

Diseases in the Familial Stomach Cancer family:

Stomach Carcinoma in Situ

Diseases related to Stomach Carcinoma in Situ via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 lip carcinoma in situ 10.5
2 esophagus carcinoma in situ 10.5
3 in situ carcinoma 9.9

Comorbidity relations with Stomach Carcinoma in Situ via Phenotypic Disease Network (PDN):


Gastric Cancer

Symptoms & Phenotypes for Stomach Carcinoma in Situ

Drugs & Therapeutics for Stomach Carcinoma in Situ

Drugs for Stomach Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fluorouracil Approved Phase 1, Phase 2 51-21-8 3385
2
Oxaliplatin Approved, Investigational Phase 1, Phase 2 61825-94-3 43805 6857599 5310940 9887054
3
nivolumab Approved Phase 1, Phase 2 946414-94-4
4
Ipilimumab Approved Phase 1, Phase 2 477202-00-9
5 Antibodies Phase 1, Phase 2
6 Antimetabolites Phase 1, Phase 2
7 Immunoglobulins Phase 1, Phase 2
8 Immunologic Factors Phase 1, Phase 2
9 Antimetabolites, Antineoplastic Phase 1, Phase 2
10 Antineoplastic Agents, Immunological Phase 1, Phase 2
11 Antibodies, Monoclonal Phase 1, Phase 2
12 Immunosuppressive Agents Phase 1, Phase 2
13
Tegafur Approved, Investigational Phase 1 17902-23-7 5386
14
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
15
leucovorin Approved Phase 1 58-05-9 143 6006
16
Levoleucovorin Approved, Investigational Phase 1 68538-85-2
17
Folic Acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
18 Antineoplastic Agents, Phytogenic Phase 1
19 Antimitotic Agents Phase 1
20 Albumin-Bound Paclitaxel Phase 1
21
s 1 (combination) Phase 1
22 Folate Phase 1
23 Vitamin B9 Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer Recruiting NCT03776487 Phase 1, Phase 2 Fluorouracil;Oxaliplatin
2 Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers Recruiting NCT03162510 Phase 1 Oxaliplatin;Albumin-Bound Paclitaxel /nab-Paclitaxel;S-1;LV

Search NIH Clinical Center for Stomach Carcinoma in Situ

Genetic Tests for Stomach Carcinoma in Situ

Anatomical Context for Stomach Carcinoma in Situ

The Foundational Model of Anatomy Ontology organs/tissues related to Stomach Carcinoma in Situ:

20
The Stomach

Publications for Stomach Carcinoma in Situ

Articles related to Stomach Carcinoma in Situ:

# Title Authors Year
1
WEEKLY clinicopathologic exercises: carcinoma in situ of stomach. ( 13087633 )
1953

Variations for Stomach Carcinoma in Situ

Expression for Stomach Carcinoma in Situ

Search GEO for disease gene expression data for Stomach Carcinoma in Situ.

Pathways for Stomach Carcinoma in Situ

GO Terms for Stomach Carcinoma in Situ

Sources for Stomach Carcinoma in Situ

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....